XRAY (XRAY)

Financial Metrics & Valuation Analysis

Enterprise Valuation (TTM)

Enterprise Value$4.82B
EV / Sales1.31
EV / EBITDA-37.95
EV / Operating Cash Flow17.98
EV / Free Cash Flow46.34

Return Metrics (TTM)

Return on Equity (ROE)-41.21%
Return on Assets (ROA)-12.01%
Return on Invested Capital (ROIC)5.08%
Return on Capital Employed (ROCE)5.37%

Yield Metrics

Earnings Yield-23.50%
Free Cash Flow Yield3.88%

Balance Sheet Strength

Net Debt / EBITDA-16.86
Current Ratio1.53
Working Capital$638.00M
Tangible Asset Value-$747.00M
Net Current Asset Value-$2.06B

Working Capital Efficiency

Days Sales Outstanding61.68
Days Payables Outstanding50.28
Operating Cycle (Days)189.62
Cash Conversion Cycle139.34

Capital Allocation

CapEx / Revenue4.46%
CapEx / Operating Cash Flow61.19%
R&D / Revenue4.29%
SG&A / Revenue39.04%

Fiscal Year 2025 Ratios

Audited annual results as of 2025-12-31

Margins

Gross Profit Margin50.00%
Operating Margin6.85%
Net Profit Margin-16.25%

Solvency

Debt / Equity1.84
Quick Ratio1.03
Cash Ratio0.24

Per Share

Revenue / Share$18.46
FCF / Share$0.52
PE Ratio-3.81